What is Vertex Pharmaceuticals's market cap?

Vertex Pharmaceuticals (VRTX) has a market capitalization of $115.45B as of June 15, 2026. Market cap is the total market value of the company's outstanding shares (share price × shares outstanding), shown here in US dollars (USD).

How is Vertex Pharmaceuticals's market cap calculated, and what currency is it in?

Market capitalization is calculated by multiplying Vertex Pharmaceuticals's share price by its total shares outstanding. Although Vertex Pharmaceuticals reports its financial statements in USD, market cap on this page is shown in US dollars (USD) for comparability with other companies.

What is the highest market cap Vertex Pharmaceuticals has reached?

Vertex Pharmaceuticals (VRTX) reached its all-time high market cap of $134.87B on November 8, 2024, based on daily closing values in our history.

What is the lowest market cap Vertex Pharmaceuticals has reached?

Vertex Pharmaceuticals (VRTX) recorded its all-time low market cap of $614.11M on November 11, 2003 in the available daily history.

Is Vertex Pharmaceuticals's market cap above or below its 5-year average?

At $115.45B, Vertex Pharmaceuticals's market cap is currently above its five-year average of $94.32B.

What was Vertex Pharmaceuticals's market cap in 2025?

Vertex Pharmaceuticals (VRTX) ended 2025 with a market cap of $116.97B.

What was Vertex Pharmaceuticals's market cap in 2026?

Vertex Pharmaceuticals (VRTX) ended 2026 with a market cap of $115.45B.

Vertex Pharmaceuticals (VRTX) Market Cap History

Current

$115.45B

As of Jun 15, 2026

5-Year Average

$94.32B

All-Time High

$134.87B

Nov 8, 2024

All-Time Low

$614.11M

Nov 11, 2003

Market cap daily chart for Vertex Pharmaceuticals (VRTX)

Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days

Market Cap growth chart for Vertex Pharmaceuticals (VRTX) from 1991 to 2026

Latest: -1.3%

Market Cap history table for Vertex Pharmaceuticals (VRTX) from 1991 to 2026


2026	$115.45B	-1.3%	−$1.51B	Jun 15, 2026	May 5, 2026
2025	$116.97B	+12.6%	+$13.11B	Dec 31, 2025	Feb 13, 2026
2024	$103.86B	-2.0%	−$2.14B	Dec 31, 2024	Feb 13, 2025
2023	$105.99B	+41.7%	+$31.17B	Dec 31, 2023	Feb 15, 2024
2022	$74.82B	+31.1%	+$17.75B	Dec 31, 2022	Feb 10, 2023
2021	$57.07B	-8.3%	−$5.18B	Dec 31, 2021	Feb 9, 2022
2020	$62.25B	+9.1%	+$5.18B	Dec 31, 2020	Feb 11, 2021
2019	$57.07B	+32.9%	+$14.12B	Dec 31, 2019	Feb 13, 2020
2018	$42.95B	+13.2%	+$5.00B	Dec 31, 2018	Feb 13, 2019
2017	$37.95B	+110.5%	+$19.92B	Dec 31, 2017	Feb 15, 2018
2016	$18.03B	-40.6%	−$12.34B	Dec 31, 2016	Feb 23, 2017
2015	$30.36B	+8.6%	+$2.41B	Dec 31, 2015	Feb 16, 2016
2014	$27.95B	+67.3%	+$11.24B	Dec 31, 2014	Feb 13, 2015
2013	$16.71B	+88.2%	+$7.83B	Dec 31, 2013	Feb 11, 2014
2012	$8.88B	+28.1%	+$1.95B	Dec 31, 2012	Mar 1, 2013
2011	$6.93B	-1.2%	−$85.60M	Dec 31, 2011	Feb 22, 2012
2010	$7.02B	-5.4%	−$404.07M	Dec 31, 2010	Feb 17, 2011
2009	$7.42B	+73.9%	+$3.15B	Dec 31, 2009	Feb 19, 2010
2008	$4.27B	+42.5%	+$1.27B	Dec 31, 2008	Feb 17, 2009
2007	$3.00B	-29.3%	−$1.24B	Dec 31, 2007	Feb 11, 2008
2006	$4.24B	+71.6%	+$1.77B	Dec 31, 2006	Mar 1, 2007
2005	$2.47B	+197.3%	+$1.64B	Dec 31, 2005	Mar 16, 2006
2004	$830.50M	+4.2%	+$33.50M	Dec 31, 2004	Mar 16, 2005
2003	$796.99M	-33.6%	−$403.63M	Dec 31, 2003	Mar 15, 2004
2002	$1.20B	-34.4%	−$630.45M	Dec 31, 2002	Mar 31, 2003
2001	$1.83B	-62.2%	−$3.01B	Dec 31, 2001	Apr 1, 2002
2000	$4.84B	+441.8%	+$3.95B	Dec 31, 2000	Mar 26, 2001
1999	$893.13M	+18.7%	+$140.48M	Dec 31, 1999	Mar 3, 2000
1998	$752.65M	-6.0%	−$48.07M	Dec 31, 1998	Mar 30, 1999
1997	$800.71M	+6.4%	+$48.38M	Dec 31, 1997	Mar 26, 1998
1996	$752.34M	+66.4%	+$300.15M	Dec 31, 1996	Mar 28, 1997
1995	$452.18M	+91.8%	+$216.47M	Dec 31, 1995	Dec 31, 1995
1994	$235.71M	+1.9%	+$4.46M	Dec 31, 1994	Dec 31, 1994
1993	$231.25M	+95.3%	+$112.86M	Dec 31, 1993	Dec 31, 1993
1992	$118.39M	+9.8%	+$10.60M	Dec 31, 1992	Dec 31, 1992
1991	$107.79M	—	—	Dec 31, 1991	Dec 31, 1991

2026$115.45B-1.3%
2025$116.97B+12.6%
2024$103.86B-2.0%
2023$105.99B+41.7%
2022$74.82B+31.1%
2021$57.07B-8.3%
2020$62.25B+9.1%
2019$57.07B+32.9%
2018$42.95B+13.2%
2017$37.95B+110.5%
2016$18.03B-40.6%
2015$30.36B+8.6%
2014$27.95B+67.3%
2013$16.71B+88.2%
2012$8.88B+28.1%
2011$6.93B-1.2%
2010$7.02B-5.4%
2009$7.42B+73.9%
2008$4.27B+42.5%
2007$3.00B-29.3%
2006$4.24B+71.6%
2005$2.47B+197.3%
2004$830.50M+4.2%
2003$796.99M-33.6%
2002$1.20B-34.4%
2001$1.83B-62.2%
2000$4.84B+441.8%
1999$893.13M+18.7%
1998$752.65M-6.0%
1997$800.71M+6.4%
1996$752.34M+66.4%
1995$452.18M+91.8%
1994$235.71M+1.9%
1993$231.25M+95.3%
1992$118.39M+9.8%
1991$107.79M—

Market Cap values are taken from Vertex Pharmaceuticals's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Market Cap at Vertex Pharmaceuticals (VRTX)

According to Vertex Pharmaceuticals's latest reported financial statements, the company's latest reported market cap is $114.45B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).

Headline figure above is from the reporting period ending March 31, 2026 (reported May 5, 2026). Chart and table below cover the full reported history back to 1991.

As of the 2026 fiscal year, Vertex Pharmaceuticals (VRTX) reported market cap of $115.45B – edged down 1.3% year-over-year.

Vertex Pharmaceuticals market cap has grown on net over the period, with a +15.1% compound annual growth rate over 2021–2026 (5 years).

Between 2025 and 2026, Vertex Pharmaceuticals market cap edged down 1.3%, falling from $116.97B to $115.45B.

The highest annual market cap of $116.97B was reported in 2025. The lowest in the available history was $107.79M in 1991.

Vertex Pharmaceuticals Market Cap by Year

Vertex Pharmaceuticals Market Cap 2026: $115.45B

2026's market cap for Vertex Pharmaceuticals came in at $115.45B, edged down 1.3% below 2025.

Vertex Pharmaceuticals Market Cap 2025: $116.97B

Vertex Pharmaceuticals posted market cap of $116.97B in 2025, grew 12.6% from 2024. This figure represents the highest annual value in the available history.

Vertex Pharmaceuticals Market Cap 2024: $103.86B

In 2024, Vertex Pharmaceuticals reported market cap of $103.86B, edged down 2.0% below 2023.

Vertex Pharmaceuticals Market Cap 2023: $105.99B

Vertex Pharmaceuticals market cap in 2023 was $105.99B, surged 41.7% from 2022.

Vertex Pharmaceuticals Market Cap 2022: $74.82B

Vertex Pharmaceuticals market cap in 2022 was $74.82B.

See more financial history for Vertex Pharmaceuticals (VRTX).

Sector peers by Market Cap

Healthcare peers of Vertex Pharmaceuticals (VRTX), ranked by their latest market cap


Eli Lilly (LLY)	$1.06T
Johnson & Johnson (JNJ)	$567.28B
AbbVie (ABBV)	$391.50B
UnitedHealth Group (UNH)	$373.28B
Merck & Co. (MRK)	$283.78B
AstraZeneca (AZN)	$274.92B
Novo Nordisk (NVO)	$195.17B
Amgen (AMGN)	$189.18B

Frequently asked questions

Vertex Pharmaceuticals (VRTX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

VRTX Overview

Counters

Income Statement

Cash Flow

Capital Return

Forecast & Valuation